Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-006246
Filing Date
2020-05-18
Accepted
2020-05-18 17:04:38
Documents
1
Period of Report
2020-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3373
  Complete submission text file 0001179110-20-006246.txt   4836
Mailing Address C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Fuhrman Alan (Reporting) CIK: 0001303521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 20890536

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations